Home › Compare › BPSR vs PLD

BPSR vs PLD: Dividend Comparison 2026

BPSR yields 3333.33% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPSR wins by $1244041712883.89M in total portfolio value
10 years
BPSR
BPSR
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full BPSR calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — BPSR vs PLD

📍 BPSR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPSRPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPSR + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BPSR pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPSR
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, BPSR beats the other by $998,508,911,156,679,300.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPSR + PLD for your $10,000?

BPSR: 50%PLD: 50%
100% PLD50/50100% BPSR
Portfolio after 10yr
$622020856448.45M
Annual income
$587,358,183,038,597,200.00/yr
Blended yield
94.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

BPSR
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPSR buys
0
PLD buys
0
No recent congressional trades found for BPSR or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPSRPLD
Forward yield3333.33% ✓3.18%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$1244041712890.40M ✓$6.50M
Annual income after 10y$1,174,716,366,071,938,000.00 ✓$5,256,436.18
Total dividends collected$1239274250481.68M ✓$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BPSR vs PLD ($10,000, DRIP)

YearBPSR PortfolioBPSR Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$344,033$333,333.33$11,255$555.24+$332.8K → BPSR
2$11,085,665$10,717,549.33$13,062$1,018.59+$11.07M → BPSR
3$334,616,633$322,754,971.08$15,903$1,926.67+$334.60M → BPSR
4$9,462,934,690$9,104,894,892.71$20,839$3,823.32+$9462.91M → BPSR
5$250,766,259,005$240,640,918,887.41$30,464$8,166.08+$250766.23M → BPSR
6$6,228,082,462,189$5,959,762,565,053.11$52,054$19,457.30+$6228082.41M → BPSR
7$144,998,525,500,125$138,334,477,265,582.72$109,886$54,188.93+$144998525.39M → BPSR
8$3,165,074,899,913,431$3,009,926,477,628,297.00$304,030$186,451.18+$3165074899.61M → BPSR
9$64,790,043,755,570,470$61,403,413,612,663,110.00$1,166,125$840,813.32+$64790043754.40M → BPSR
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$6,504,190$5,256,436.18+$1244041712883.89M → BPSR

BPSR vs PLD: Complete Analysis 2026

BPSR — Stock

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

Full BPSR Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this BPSR vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPSR vs SCHDBPSR vs JEPIBPSR vs OBPSR vs KOBPSR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.